Details of the Drug

General Information of Drug (ID: DMAJH1B)

• Drug Name: Anti-CD38 CAR-T cell therapy

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1	[1]

• Cross-matching ID: TTD ID: D0Y7LV

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)